EcoDrugPlus

Dihydrofolate Reductase

Ensembl ID : ENSDNOG00000038425
Gene Symbol: DHFR
3 Cross references
353 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSDNOG00000002630
Gene Symbol: DPP4
2 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSDNOG00000047270
Gene Symbol: DDR2
4 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSDNOG00000044944
Gene Symbol: DRD1
4 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSDNOG00000007008
Gene Symbol: DRD2
4 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSDNOG00000012315
Gene Symbol: DRD3
2 Cross references
209 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSDNOG00000002203
Gene Symbol: DRD5
4 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSDNOG00000005336
Gene Symbol: ENPP2
4 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSDNOG00000044897
Gene Symbol: EGLN2
4 Cross references
195 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSDNOG00000036494
Gene Symbol: EGLN3
4 Cross references
208 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSDNOG00000037320
Gene Symbol: ELANE
2 Cross references
91 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSDNOG00000005938
Gene Symbol: EPAS1
4 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).